← Leaderboards
David B Sykes
Massachusetts General Hospital
$998,320
Attributed
$1,231,755
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $262.9K · FY2011–23$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,231,755 · 3
By mechanism
K08$677,072 · 1
R21$466,870 · 1
R03$87,813 · 1
Top collaborators
- Jens Peter Wrammert2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Pouneh Khadejeh Fazeli$3,583,785
- Michael K Mansour$3,170,782
- Eng H. Lo$32,456,318
- Mingming Ning$8,518,949
- Wenjun Deng$522,065
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationCellsIn VivoIn VitroGene ExpressionLeukemiaLeukemic CellMuramidaseGene MutationAcute Promyelocytic LeukemiaAdultGenesAffectClassificationDiagnosisEngineeringCollaborationsDifferentiation TherapyBiological ModelsChemotherapyExperimental StudyCell LineInhibitor/AntagonistMaintenance
Grant awards (8)
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome$203,935
R21 · FY2023 · AI · contact PI
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome$262,935
R21 · FY2022 · AI · contact PI
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia$169,268
K08 · FY2020 · CA · contact PI
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia$169,268
K08 · FY2019 · CA · contact PI
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia$169,268
K08 · FY2018 · CA · contact PI
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia$169,268
K08 · FY2017 · CA · contact PI
Discovering small molecules that overcome differentiation arrest in acute myeloid$43,563
R03 · FY2012 · DA · contact PI
Discovering small molecules that overcome differentiation arrest in acute myeloid$44,250
R03 · FY2011 · DA · contact PI